Key Takeaways Masimo secured FDA clearance for expanded use of O3 Regional Oximetry with delta hemoglobin.The approval covers cerebral and somatic applications across all ages, including neonates.O3 now provides deeper insight into oxygen imbalances, aiding precise interventions in critical care.Masimo (MASI) recently secured FDA 510(k) clearance for expanded indications of its O3 Regional Oximetry with delta hemoglobin parameters. These parameters track relative changes in hemoglobin levels, helping clinic ...